Healthcare -
Biotechnology - NASDAQ - US
$ 21.98
-1.7 %
$ 16.2 B
Market Cap
-95.57
P/E
SMMT - TOTAL CURRENT LIABILITIES
Total Current Liabilities SMMT - Summit Therapeutics Inc.
20.4 M
LAST VALUE
-10.76%
2 YEAR CAGR
3.87%
5 YEAR CAGR
20.80%
10 YEAR CAGR